NCT04564612View on ClinicalTrials.gov

Study of BIIB091 Formulations in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

September 7, 2022

Study Completion Date

September 7, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

BIIB091

Administered as specified in the treatment arm

DRUG

Rabeprazole

Administered as specified in the treatment arm

DRUG

Itraconazole

Administered as specified in the treatment arm

Trial Locations (1)

Unknown

Research Site, Nottingham

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT04564612 - Study of BIIB091 Formulations in Healthy Participants | Biotech Hunter | Biotech Hunter